Tuberculosis Vaccine Market 2022-2028

Title:Global Tuberculosis Vaccine Market Size, Share and Trends Analysis Report, By Type (Immunotherapeutic Vaccine and Booster Vaccine), By Application (Hospitals, Clinics, and Others), Forecast Period (2022-2028).

The global tuberculosis vaccine market is anticipated to grow at a substantial CAGR of 8.4% during the forecast period. Several types of research are in pipeline which is significantly supporting the market growth. According to the WHO's global tuberculosis (TB) report 2021, 25 medicines were in Phase I, Phase II, or Phase III studies in August 2021 for the treatment of drug-susceptible TB, MDR-TB, or TB infection. Besides, in April 2021, EDCTP and the Amsterdam Institute for Global Health and Development (AIGHD) launched a global TB vaccine R&D roadmap at the Virtual Global Forum on TB Vaccines. The project was conducted in close collaboration with the World Health Organization.

In addition, the players operating in the market are also helping significantly in the growth of the market. For instance, in July 2021, Biofabri and IAVI had partnered for efficacy trials of tuberculosis (TB) vaccine candidate MTBVAC. Additionally, side effects occurring from the vaccinations and the government approval time for the vaccine are the major factors that may hinder the growth of the market. Increasing awareness about vaccination and growing government funding for vaccination programs may bring new growth opportunities to the market during the forecast period.

The global tuberculosis vaccine market is segmented based on type and application. Based on type, the market is bifurcated into immunotherapeutic vaccines and booster vaccines. Based on application, the market is further sub-categorized into hospitals, clinics, and others. The immunotherapeutic vaccines such as the immune BCG segment accounted for the highest share in the past and are also the fastest-growing segment during the forecast period.

Geographically tuberculosis vaccine market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific region will show the fastest growth in this market. Countries such as India, China, Indonesia, the Philippines, and Pakistan have a high number of TB cases. And according to the World Health Organization, these countries accounted for 60% of the total TB deaths in 2020. Moreover, sophisticated healthcare government policies toward exterminating TB, and better healthcare infrastructure may support the North American region to maintain its dominance in the market during the forecast period.

The major market players in the global tuberculosis vaccine market include Pfizer Inc., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Ltd., Taj Pharmaceuticals Ltd., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global tuberculosis vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.

• Whitepapers, research papers, and news blogs.

• Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

• Global tuberculosis Vaccine Market Research and Analysis by Type
• Global tuberculosis Vaccine Market Research and Analysis by Application

The Report Covers:

• Comprehensive research methodology of the global tuberculosis vaccine market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global tuberculosis vaccine market.
• Insights about market determinants that are stimulating the global tuberculosis vaccine market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.